TABLE 2.
Study | Randomized | Allocation concealed |
Key outcomes similar at baseline |
Eligibility criteria specified |
Single blind | Key descriptive statistics reported |
Intent-to- treat analysis |
---|---|---|---|---|---|---|---|
Battaglini32 | Yes | No | Yes | Yes | No | Yes | No |
Battaglini20 | Yes | Yes | Yes | Yes | No | Yes | No |
Cadmus29 | Yes | No | Yes | Yes | No | Yes | No |
Chandwani28 | Yes | Yes | Yes | Yes | No | Yes | No |
Courneya22 | Yes | Yes | Yes | Yes | No | Yes | Yes |
Dolan23 | Yes | Yes | Yes | Yes | No | Yes | Yes |
Hornsby16 | Yes | Yes | Yes | No | Yes | Yes | Yes |
Husebø25 | Yes | No | Yes | Yes | Yes | Yes | No |
Hwang26 | Yes | No | Yes | Yes | No | Yes | No |
Kim30 | Yes | No | Yes | Yes | No | Yes | No |
Mock31 | No | No | Yes | Yes | No | Yes | No |
Mock19 | Yes | No | Yes | Yes | No | Yes | No |
Schmidt21 | Yes | Yes | Yes | Yes | No | Yes | Yes |
Schwartz24 | Yes | No | Yes | Yes | No | Yes | No |
Vadiraja27 | Yes | No | Yes | Yes | No | Yes | No |
Wang17 | Yes | No | Yes | Yes | No | Yes | No |
Yang18 | Yes | No | Yes | Yes | No | Yes | No |